Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2015

  • ID: 3243319
  • Company Profile
  • Global Markets Direct
1 of 4
Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2015

Summary

This, ‘Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Kyowa Hakko Kirin Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kyowa Hakko Kirin Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kyowa Hakko Kirin Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kyowa Hakko Kirin Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Kyowa Hakko Kirin Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Kyowa Hakko Kirin Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kyowa Hakko Kirin Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kyowa Hakko Kirin Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kyowa Hakko Kirin Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kyowa Hakko Kirin Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kyowa Hakko Kirin Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables
List of Figures
Kyowa Hakko Kirin Co., Ltd. Snapshot
Kyowa Hakko Kirin Co., Ltd. Overview
Key Information
Key Facts
Kyowa Hakko Kirin Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Kyowa Hakko Kirin Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products Glance
Kyowa Hakko Kirin Co., Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Drug Profiles
KW-3357
Product Description
Mechanism of Action
R&D Progress
tivozanib
Product Description
Mechanism of Action
R&D Progress
benralizumab
Product Description
Mechanism of Action
R&D Progress
brodalumab
Product Description
Mechanism of Action
R&D Progress
darbepoetin alfa (recombinant)
Product Description
Mechanism of Action
R&D Progress
granisetron ER
Product Description
Mechanism of Action
R&D Progress
istradefylline
Product Description
Mechanism of Action
R&D Progress
mogamulizumab
Product Description
Mechanism of Action
R&D Progress
tivantinib
Product Description
Mechanism of Action
R&D Progress
ASKP-1240
Product Description
Mechanism of Action
R&D Progress
bardoxolone methyl
Product Description
Mechanism of Action
R&D Progress
KHK-4577
Product Description
Mechanism of Action
R&D Progress
KRN-23
Product Description
Mechanism of Action
R&D Progress
romiplostim
Product Description
Mechanism of Action
R&D Progress
BIW-8962
Product Description
Mechanism of Action
R&D Progress
KHK-2823
Product Description
Mechanism of Action
R&D Progress
KHK-2898
Product Description
Mechanism of Action
R&D Progress
KHK-4083
Product Description
Mechanism of Action
R&D Progress
KHK-6640
Product Description
Mechanism of Action
R&D Progress
DsiRNA to Inhibit KRAS for Solid Tumor
Product Description
Mechanism of Action
R&D Progress
DsiRNAs for Solid Tumor
Product Description
Mechanism of Action
R&D Progress
K-685
Product Description
Mechanism of Action
R&D Progress
K-756
Product Description
Mechanism of Action
R&D Progress
Ki-26894
Product Description
Mechanism of Action
R&D Progress
KM-2812
Product Description
Mechanism of Action
R&D Progress
KW-6356
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Mitotic Kinesin Eg5 for Ovarian Cancer
Product Description
Mechanism of Action
R&D Progress
Z-3G1
Product Description
Mechanism of Action
R&D Progress
Bispecific Antibodies for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
K-777
Product Description
Mechanism of Action
R&D Progress
Small Molecules Targeting Protein-Protein Interactions for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Kyowa Hakko Kirin Co., Ltd. - Pipeline Analysis
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Target
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Route of Administration
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Molecule Type
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates
Kyowa Hakko Kirin Co., Ltd. - Dormant Projects
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
AGS-003
AGS-004
darbepoetin alfa (recombinant)
KHK-2866
KHK-6188
KRN-330
KRX-0601
KW-2449
KW-2450
KW-2478
KW-7158
litronesib
mogamulizumab
pibrozelesin hydrobromide
tivantinib
tivozanib
Kyowa Hakko Kirin Co., Ltd. - Company Statement
Kyowa Hakko Kirin Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Kyowa Hakko Kirin Co., Ltd., Key Information
Kyowa Hakko Kirin Co., Ltd., Key Facts
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Indication, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2015
Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2015
Kyowa Hakko Kirin Co., Ltd. - Partnered Products in Pipeline, 2015
Kyowa Hakko Kirin Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products in Pipeline, 2015
Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Kyowa Hakko Kirin Co., Ltd. - Pre-Registration, 2015
Kyowa Hakko Kirin Co., Ltd. - Filing rejected/Withdrawn, 2015
Kyowa Hakko Kirin Co., Ltd. - Phase III, 2015
Kyowa Hakko Kirin Co., Ltd. - Phase II, 2015
Kyowa Hakko Kirin Co., Ltd. - Phase I, 2015
Kyowa Hakko Kirin Co., Ltd. - Preclinical, 2015
Kyowa Hakko Kirin Co., Ltd. - Discovery, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Target, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Route of Administration, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Molecule Type, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates, 2015
Kyowa Hakko Kirin Co., Ltd. - Dormant Developmental Projects,2015
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products, 2015
Kyowa Hakko Kirin Co., Ltd., Other Locations
Kyowa Hakko Kirin Co., Ltd., Subsidiaries

List of Figures
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Indication, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2015
Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2015
Kyowa Hakko Kirin Co., Ltd. - Partnered Products in Pipeline, 2015
Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products in Pipeline, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Target, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll